Interestingly, low glutamate levels in the cerebrospinal fluid (CSF) of SLC13A5 patients [39] might impact the balance between excitatory and inhibitory neurotransmission, leading to epilepsy. This evidence concerns the gene SLC13A5 and epilepsy.